The success of Sildenafil initially drove a surge for pharma, nevertheless recent shifts present a uncertain outlook for investors. Generic alternatives are eroding revenue, and ongoing legal battles add more https://aprilmxjf765915.loginblogin.com/49343562/viagra-and-pharma-a-volatile-bet